• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’

2

Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEO

3

Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them rich

1

IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’

2

Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEO

3

Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them rich
HealthAlzheimer's

A Diabetes Drug Could Help Alzheimer’s Patients Reverse Memory Loss

By
Emily Price
Emily Price
Down Arrow Button Icon
By
Emily Price
Emily Price
Down Arrow Button Icon
January 2, 2018, 1:57 PM ET
Alzheimers-dementia-brain-research
Alzheimers and dementia research, a brain scan in multi well tray used for research experiments in laboratory.Andrew Brookes—Getty Images/Cultura RF
Add Fortune on Google for similar content.

There have been no new Alzheimer’s treatments introduced in the past 15 years, but new research suggests that a drug traditionally used to treat diabetes could be useful in treating Alzheimer’s as well. British researchers found that the drug “significantly reversed memory loss” in mice, which opens the door to it being used to reduce memory loss in humans in the future.

The study involved giving a triple-receptor drug to mice that had Alzheimer’s and age-related brain deterioration. After they were given the drug, the mice were asked to go through a maze that tested their memory.

Mice that were given the drug showed reduced plaque buildup in the brain (a sign of Alzheimer’s) and overall improved memory. The cellular health of the mice that took the drug was also improved, as was inflammation that was previously seen on their brains, reports Genetic Engineering and Biology News.

Researchers have been exploring the connection between Alzheimer’s and diabetes for years. The study’s findings could help further existing research as well as move toward finding better treatments for those suffering with Alzheimer’s. The number of people with Alzheimer’s is currently expected to double by 2060.

About the Author
By Emily Price
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Latest in Health


    Most Popular

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.